Robert C Gallo

This inventor holds 61 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent, primarily in HIV Research (CPC class 5303). Top assignees: The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services, University System of Maryland. Active years: 1985-2016.

USPTO Granted Patents = 61 (Patent Applications = 2)

% Patents Active = 96.7

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.8

ph-index = 18

Forward Citations = 941(Granted Patents)

Forward Citations (Not Self Cited) = 881(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Baltimore, MD (US) (2003)
Bethesda, MD (US) (1985 - 2016)

Company Filing History:

15 out of 1,217

The United States of America as Represented by the Department of Health

patents

11 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

11 out of 2,020

University System of Maryland

patents

4. 6 out of 2,202

The United States of America as Represented by the Secretary of

Nobel Biosciences LLC

patents

7. 2 out of 255

The United States of America

Daiichi Pharmaceutical Co., Ltd.

patents

12. 1 out of 5,011

Hoffmann-La Roche Inc.

patents

13. 1 out of 28

The Government of the United States of America, as Represented by the

patents

14. 1 out of 34

Virogenetics Corporation

patents

15. 10 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2016

Loading Chart...

Areas of Expertise:

HIV-1 DNA

Cloning

Polypeptides

Chemokines

Cancer Treatment

Antibodies

Immune Response

Chorionic Gonadotropin

Viral Infection

LAV Antigens

Reverse Transcriptase

Hematopoiesis

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9328391 - Cloning and expression of HIV-1 DNA (2016-05-03),

2. 9309574 - Molecular cloning of HIV-1 from immortalized cell lines (2016-04-12),

3. 9175077 - Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) (2015-11-03),

4. 8785609 - Cloning and expression of HTLV-III DNA (2014-07-22),

5. 7994278 - Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) (2011-08-09),

6. 7815916 - Cloning and expression of HTLV-III DNA (2010-10-19),

7. 7708983 - Directional induction of immune response by co-administration of antigens with chemokines (2010-05-04),

8. 7232654 - DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) (2007-06-19),

9. 7217508 - Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) (2007-05-15),

10. 7205102 - Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA (2007-04-17),

11. RE38824 - Antibodies against human herpes virus-6(HHV-6) and method of use (2005-10-10),

12. 6858712 - Cloning and expression of HTLV-III DNA (2005-02-22),

13. 6805882 - Therapeutic fractions of sources of HCG (2004-10-19),

14. 6699834 - Method for treating cancer (2004-03-02),

15. 6699656 - Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin (2004-03-02),

Title: The Remarkable Journey of Robert C. Gallo

Introduction:

Robert C. Gallo, a distinguished inventor, was born in Bethesda, MD (US). He is renowned for his groundbreaking contributions to the field of medical research, particularly in the area of virology.

Latest Patents:

Robert C. Gallo holds several patents related to the development of diagnostic tests for various viral infections, including HIV/AIDS. His innovative work has significantly impacted the healthcare industry and has saved countless lives around the world.

Career Highlights:

Throughout his illustrious career, Robert C. Gallo has served as a leading figure in the fight against infectious diseases. He is credited with the co-discovery of the human immunodeficiency virus (HIV) as the cause of AIDS, a pivotal moment in the history of medicine. His research has paved the way for the development of life-saving treatments and vaccines.

Collaborations:

Robert C. Gallo has collaborated with numerous scientists, researchers, and healthcare professionals from around the globe. His collaborative efforts have resulted in groundbreaking discoveries and have furthered our understanding of viral diseases.

Conclusion:

In conclusion, Robert C. Gallo's dedication to scientific innovation and his relentless pursuit of advancements in virology have solidified his legacy as a pioneering inventor in the field of medical research. His contributions continue to have a profound impact on public health and the fight against infectious diseases worldwide.